Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review

Clinical Reviews in Allergy and Immunology

Volumn 50, Issue 3, 2016, Pages 333-344

  Wu, Haijing ^a   Zhao, Ming ^a   Yoshimura, Akihiko ^b   Chang, Christopher ^c   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune; DNA methylation; Epigenetics; Histone modifications; lncRNAs; miRNAs; Transcription factors

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR ALPHA; DEATH RECEPTOR 3; DNA; DNA METHYLTRANSFERASE; EARLY B CELL FACTOR 1; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; LONG UNTRANSLATED RNA; MICRORNA; REGULATORY FACTOR X BOX 1; SMAD3 PROTEIN; SMAD4 PROTEIN; STAT5 PROTEIN; TEN ELEVEN TRANSLOCATION METHYLCYTOSINE DIOXYGENASE 1; TEN ELEVEN TRANSLOCATION METHYLCYTOSINE DIOXYGENASE 2; TEN ELEVEN TRANSLOCATION METHYLCYTOSINE DIOXYGENASE 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E4BP4; TRANSCRIPTION FACTOR FLI1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; CARRIER PROTEIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; PROTEIN BINDING;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING SITE; CHROMATIN; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; HISTONE MODIFICATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UPREGULATION; ANIMAL; AUTOIMMUNE DISEASES; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CARRIER PROTEINS; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; MICRORNAS; PROTEIN BINDING; RNA, LONG NONCODING; TRANSCRIPTION FACTORS;

EID: 84960435106     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-016-8534-y     Document Type: Review

References (137)

1. Lu Q (2014) Unmet needs in autoimmunity and potential new tools. Clin Rev Allergy Immunol 47:111–8
2. Wandstrat A, Wakeland E (2001) The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2:802–9
3. Rhodes B, Vyse TJ (2008) The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 47:1603–11
4. Alarcon-Riquelme ME (2007) Recent advances in the genetics of autoimmune diseases. Ann N Y Acad Sci 1110:1–9
5. Floreani A, Leung PS, Gershwin ME (2015) Environmental basis of autoimmunity Clin Rev Allergy Immunol
6. Jeffries MA, Sawalha AH (2011) Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents. Int J Clin Rheumatol 6:423–39
7. Ballestar E (2010) Epigenetics lessons from twins: prospects for autoimmune disease. Clin Rev Allergy Immunol 39:30–41
8. Brown CC, Wedderburn LR (2015) Genetics: mapping autoimmune disease epigenetics: what’s on the horizon? Nat Rev Rheumatol 11:131–2
9. Jeffries MA, Sawalha AH (2015) Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? Expert Rev Clin Immunol 11:45–58
10. Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL et al (1993) Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 92:38–53
11. Sanchez-Pernaute O, Ospelt C, Neidhart M, Gay S (2008) Epigenetic clues to rheumatoid arthritis. J Autoimmun 30:12–20
12. Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman C et al (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 15:9–15
13. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL (2008) The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9:516–26
14. Koch MW, Metz LM, Kovalchuk O (2013) Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis. Trends Mol Med 19:23–30
15. Kucukali CI, Kurtuncu M, Coban A, Cebi M, Tuzun E (2014) Epigenetics of multiple sclerosis: an updated review. Neuromolecular Med
16. Strickland FM, Li Y, Johnson K, Sun Z, Richardson BC (2015) CD4(+) T cells epigenetically modified by oxidative stress cause lupus-like autoimmunity in mice. J Autoimmun 62:75–80
17. Bao Y, Cao X (2015) Epigenetic control of B cell development and B-cell-related immune disorders. Clin Rev Allergy Immunol
18. Renauer P, Coit P, Sawalha AH (2015) Epigenetics and vasculitis: a comprehensive review. Clin Rev Allergy Immunol
19. Saito Y, Saito H, Liang G, Friedman JM (2014) Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol 47:128–35
20. Bernstein BE, Meissner A, Lander ES (2007) The mammalian epigenome. Cell 128:669–81
21. Denis H, Ndlovu MN, Fuks F (2011) Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep 12:647–56
22. Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M et al (2009) Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114:144–7
23. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6–21
24. Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89–97
25. Fan S, Zhang X (2009) CpG island methylation pattern in different human tissues and its correlation with gene expression. Biochem Biophys Res Commun 383:421–5
26. Perini G, Diolaiti D, Porro A, Della Valle G (2005) In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci U S A 102:12117–22
27. Kim J, Kollhoff A, Bergmann A, Stubbs L (2003) Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3. Hum Mol Genet 12:233–45
28. Chatterjee R, Vinson C (1819) CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim Biophys Acta 2012:763–70
29. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN et al (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386–9
30. Medvedeva YA, Khamis AM, Kulakovskiy IV, Ba-Alawi W, Bhuyan MS, Kawaji H et al (2014) Effects of cytosine methylation on transcription factor binding sites. BMC Genomics 15:119
31. Ali I, Seker H (2010) A comparative study for characterisation and prediction of tissue-specific DNA methylation of CpG islands in chromosomes 6, 20 and 22. Conf Proc IEEE Eng Med Biol Soc 2010:1832–5
32. Ghosh S, Yates AJ, Fruhwald MC, Miecznikowski JC, Plass C, Smiraglia D (2010) Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues. Epigenetics 5:527–38
33. Cohen CJ, Crome SQ, MacDonald KG, Dai EL, Mager DL, Levings MK (2011) Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J Immunol 187:5615–26
34. Ivascu C, Wasserkort R, Lesche R, Dong J, Stein H, Thiel A et al (2007) DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas. Int J Biochem Cell Biol 39:1523–38
35. Perera A, Eisen D, Wagner M, Laube SK, Kunzel AF, Koch S et al (2015) TET3 is recruited by REST for context-specific hydroxymethylation and induction of gene expression. Cell Rep
36. Hervouet E, Vallette FM, Cartron PF (2010) Dnmt1/transcription factor interactions: an alternative mechanism of DNA methylation inheritance. Genes Cancer 1:434–43
37. Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA (2006) STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood 108:1058–64
38. Rothbart SB, Strahl BD (1839) Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 2014:627–43
39. Peserico A, Simone C (2011) Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol 2011:371832
40. Renaudineau Y, Youinou P (2011) Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med 60:10–6
41. Black JC, Van Rechem C, Whetstine JR (2012) Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 48:491–507
42. Gregory PD, Wagner K, Horz W (2001) Histone acetylation and chromatin remodeling. Exp Cell Res 265:195–202
43. Chuang HC, Chang CW, Chang GD, Yao TP, Chen H (2006) Histone deacetylase 3 binds to and regulates the GCMa transcription factor. Nucleic Acids Res 34:1459–69
44. Yao YL, Yang WM, Seto E (2001) Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol 21:5979–91
45. Katto J, Engel N, Abbas W, Herbein G, Mahlknecht U (2013) Transcription factor NFkappaB regulates the expression of the histone deacetylase SIRT1. Clin Epigenetics 5:11
46. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83–6
47. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–79
48. Inui M, Martello G, Piccolo S (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11:252–63
49. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–33
50. Baltimore D, Boldin MP, O’Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9:839–45
51. O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10:111–22
52. Yan S, Yim LY, Lu L, Lau CS, Chan VS (2014) MicroRNA regulation in systemic lupus erythematosus pathogenesis. Immune Netw 14:138–48
53. Johnson SM, Lin SY, Slack FJ (2003) The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter. Dev Biol 259:364–79
54. Biemar F, Zinzen R, Ronshaugen M, Sementchenko V, Manak JR, Levine MS (2005) Spatial regulation of microRNA gene expression in the Drosophila embryo. Proc Natl Acad Sci U S A 102:15907–11
55. Olson EN (2006) Gene regulatory networks in the evolution and development of the heart. Science 313:1922–7
56. Arora S, Rana R, Chhabra A, Jaiswal A, Rani V (2013) miRNA-transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics 288:77–87
57. Chen CY, Chen ST, Fuh CS, Juan HF, Huang HC (2011) Coregulation of transcription factors and microRNAs in human transcriptional regulatory network. BMC Bioinformatics 12(Suppl 1):S41
58. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610
59. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A et al (2012) Landscape of transcription in human cells. Nature 489:101–8
60. International Human Genome Sequencing C (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931–45
61. Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145–66
62. Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K et al (2013) Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493:231–5
63. Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, Grander D et al (2013) A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 20:440–6
64. Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–61
65. Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C et al (2014) The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A 111:1002–7
66. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL et al (2013) A long noncoding RNA mediates both activation and repression of immune response genes. Science 341:789–92
67. Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S et al (2014) The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 344:310–3
68. Hu G, Tang Q, Sharma S, Yu F, Escobar TM, Muljo SA et al (2013) Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol 14:1190–8
69. Heward JA, Lindsay MA (2014) Long non-coding RNAs in the regulation of the immune response. Trends Immunol 35:408–19
70. Hrdlickova B, Kumar V, Kanduri K, Zhernakova DV, Tripathi S, Karjalainen J et al (2014) Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell-type specificity. Genome Med 6:88
71. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y et al (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472:120–4
72. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R et al (2008) The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322:1717–20
73. Chen R, Yang Z, Zhou Q (2004) Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. J Biol Chem 279:4153–60
74. Sharma S, Findlay GM, Bandukwala HS, Oberdoerffer S, Baust B, Li Z et al (2011) Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci U S A 108:11381–6
75. Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, Pena R et al (2008) A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 22:756–69
76. Annilo T, Kepp K, Laan M (2009) Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression. BMC Mol Biol 10:81
77. D’Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369:587–96
78. Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 48–49:10–3
79. Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96:464–71
80. Takeno M, Nagafuchi H, Kaneko S, Wakisaka S, Oneda K, Takeba Y et al (1997) Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J Immunol 158:3529–38
81. Santulli-Marotto S, Retter MW, Gee R, Mamula MJ, Clarke SH (1998) Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8:209–19
82. Gatto M, Zen M, Ghirardello A, Bettio S, Bassi N, Iaccarino L et al (2013) Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 12:523–36
83. Ghodke-Puranik Y, Niewold TB (2015) Immunogenetics of systemic lupus erythematosus: a comprehensive review. J Autoimmun 64:125–36
84. Kuhn A, Wenzel J, Weyd H (2014) Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. Clin Rev Allergy Immunol 47:148–62
85. Meroni PL, Penatti AE (2015) Epigenetics and systemic lupus erythematosus: unmet needs. Clin Rev Allergy Immunol
86. Cannat A, Seligmann M (1968) Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin Exp Immunol 3:99–105
87. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J et al (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20:170–9
88. Zhao M, Liu S, Luo S, Wu H, Tang M, Cheng W et al (2014) DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 54:127–36
89. Zhou Y, Qiu X, Luo Y, Yuan J, Li Y, Zhong Q et al (2011) Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells. Lupus 20:1365–71
90. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S et al (2011) MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 63:1376–86
91. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X et al (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184:6773–81
92. Shi L, Zhang Z, Yu AM, Wang W, Wei Z, Akhter E et al (2014) The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS One 9, e93846
93. Zhao M, Sun Y, Gao F, Wu X, Tang J, Yin H et al (2010) Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun 35:58–69
94. Zhao M, Wu X, Zhang Q, Luo S, Liang G, Su Y et al (2010) RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res Ther 12:R227
95. Zhao M, Liu Q, Liang G, Wang L, Luo S, Tang Q et al (2013) E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients. J Autoimmun 41:152–60
96. Hedrich CM, Crispin JC, Rauen T, Ioannidis C, Apostolidis SA, Lo MS et al (2012) cAMP response element modulator alpha controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc Natl Acad Sci U S A 109:16606–11
97. Luo S, Liu Y, Liang G, Zhao M, Wu H, Liang Y et al (2015) The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clin Epigenetics 7:24
98. Kourilovitch M, Galarza-Maldonado C, Ortiz-Prado E (2014) Diagnosis and classification of rheumatoid arthritis. J Autoimmun 48–49:26–30
99. Zhu X, Song Y, Huo R, Zhang J, Sun S, He Y et al (2015) Cyr61 participates in the pathogenesis of rheumatoid arthritis by promoting proIL-1beta production by fibroblast-like synoviocytes through an AKT-dependent NF-kappaB signaling pathway. Clin Immunol 157:187–97
100. Klein K, Gay S (2015) Epigenetics in rheumatoid arthritis. Curr Opin Rheumatol 27:76–82
101. Kuchen S, Seemayer CA, Rethage J, von Knoch R, Kuenzler P, Beat AM et al (2004) The L1 retroelement-related p40 protein induces p38delta MAP kinase. Autoimmunity 37:57–65
102. Grabiec AM, Tak PP, Reedquist KA (2008) Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on? Arthritis Res Ther 10:226
103. Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T et al (2009) MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 60:1294–304
104. Muller N, Doring F, Klapper M, Neumann K, Schulte DM, Turk K et al (2014) Interleukin-6 and tumour necrosis factor-alpha differentially regulate lincRNA transcripts in cells of the innate immune system in vivo in human subjects with rheumatoid arthritis. Cytokine 68:65–8
105. Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M et al (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136:62–74
106. Takami N, Osawa K, Miura Y, Komai K, Taniguchi M, Shiraishi M et al (2006) Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 54:779–87
107. Bull MJ, Williams AS, Mecklenburgh Z, Calder CJ, Twohig JP, Elford C et al (2008) The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J Exp Med 205:2457–64
108. Suarez-Alvarez B, Rodriguez RM, Fraga MF, Lopez-Larrea C (2012) DNA methylation: a promising landscape for immune system-related diseases. Trends Genet 28:506–14
109. Kosmaczewska A, Ciszak L, Swierkot J, Szteblich A, Kosciow K, Frydecka I (2015) Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors. Inflammation 38:765–74
110. Xie Z, Chang C, Zhou Z (2014) Molecular mechanisms in autoimmune type 1 diabetes: a critical review. Clin Rev Allergy Immunol 47:174–92
111. Burgio E, Lopomo A, Migliore L (2015) Obesity and diabetes: from genetics to epigenetics. Mol Biol Rep 42:799–818
112. Noble JA (2015) Immunogenetics of type 1 diabetes: a comprehensive review. J Autoimmun 64:101–12
113. Dang MN, Buzzetti R, Pozzilli P (2013) Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab Res Rev 29:8–18
114. Stefan M, Zhang W, Concepcion E, Yi Z, Tomer Y (2014) DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J Autoimmun 50:33–7
115. Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R (2008) Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57:3189–98
116. Elboudwarej E, Cole M, Briggs FB, Fouts A, Fain PR, Quach H et al (2016) Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins. Journal of autoimmunity
117. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D et al (2008) Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283:26771–81
118. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK et al (2009) Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58:1229–36
119. Wang Z, Zheng Y, Hou C, Yang L, Li X, Lin J et al (2013) DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes. J Autoimmun 41:50–9
120. Tan T, Xiang Y, Chang C, Zhou Z (2014) Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. Clin Rev Allergy Immunol 47:234–43
121. Bettini ML, Pan F, Bettini M, Finkelstein D, Rehg JE, Floess S et al (2012) Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36:717–30
122. Hudson M, Fritzler MJ (2014) Diagnostic criteria of systemic sclerosis. J Autoimmun 48–49:38–41
123. Ciechomska M, van Laar JM, O’Reilly S (2014) Emerging role of epigenetics in systemic sclerosis pathogenesis. Genes Immun 15:433–9
124. Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M et al (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62:1733–43
125. Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S et al (2009) Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 38:369–74
126. Lian X, Xiao R, Hu X, Kanekura T, Jiang H, Li Y et al (2012) DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum 64:2338–45
127. Wang YY, Wang Q, Sun XH, Liu RZ, Shu Y, Kanekura T et al (2014) DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis. Br J Dermatol 171:39–47
128. Wang Y, Shu Y, Xiao Y, Wang Q, Kanekura T, Li Y et al (2014) Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis. Clin Epigenetics 6:25
129. Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, Silver RM et al (2003) Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 163:571–81
130. Wang Y, Fan PS, Kahaleh B (2006) Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 54:2271–9
131. Broen JC, Coenen MJ, Radstake TR (2011) Deciphering the genetic background of systemic sclerosis. Expert Rev Clin Immunol 7:449–62
132. Huber LC, Distler JH, Moritz F, Hemmatazad H, Hauser T, Michel BA et al (2007) Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum 56:2755–64
133. Hollenbach JA, Oksenberg JR (2015) The immunogenetics of multiple sclerosis: a comprehensive review. J Autoimmun 64:13–25
134. Yang H, Lee SM, Gao B, Zhang J, Fang D (2013) Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation. J Biol Chem 288:37256–66
135. Liu B, Tahk S, Yee KM, Fan G, Shuai K (2010) The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science 330:521–5
136. Guan H, Nagarkatti PS, Nagarkatti M (2011) CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis. J Immunol 186:6955–64
137. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K et al (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30:80–91